Lung transplantation and interstitial lung disease
Lung transplantation and interstitial lung disease
复制标题
肺移植和间质性肺疾病
DOI：
--
复制
发表时间：
2005
影响因子：
3.3
通讯作者：
T. Hodges
中科院分区：
文献类型：
--
作者：
R. Alalawi;T. Whelan;R. Bajwa;T. Hodges
综述目的间质性肺病包括一组异质性疾病，可导致相当数量的患者呼吸功能不全和死亡。肺移植是选定的候选患者的一种治疗选择。最新发现的适应症、移植程序选择和结果仍在继续演变.不同的受体合并症影响间质性肺病患者的手术选择。选择单肺移植，双肺移植保留给有化脓性肺部疾病和肺动脉高压的患者。间质性肺病患者特有的问题影响疾病的发病率、死亡率和复发率。摘要肺移植是治疗间质性肺疾病呼吸衰竭的有效方法，移植后的存活率与其他疾病的移植受者相似。
Purpose of review Interstitial lung disease includes a heterogeneous group of disorders that leads to respiratory insufficiency and death in a significant number of patients. Lung transplantation is a therapeutic option in select candidates. Recent findings The indications, transplant procedure options, and outcomes continue to evolve. Various recipient comorbidities influence the choice of procedure in patients with interstitial lung disease. Single lung transplants are used as the procedure of choice and bilateral transplants are reserved for patients with suppurative lung disease and patients with pulmonary hypertension. Issues unique to patients with interstitial lung disease affect the morbidity, mortality and recurrence of the disease. Summary Lung transplantation is an effective therapy for respiratory failure in interstitial lung disease with survival following transplant being similar to that achieved in transplant recipients with other diseases.
肺同种异体移植受者结节病的复发。
DOI：
10.1164/ajrccm/148.5.1373
发表时间：
1993
期刊：
The American review of respiratory disease
影响因子：
--
作者：
Johnson,BA;Duncan,SR;Ohori,NP;Paradis,IL;Yousem,SA;Grgurich,WF;Dauber,JH;Griffith,BP
通讯作者：
Griffith,BP
DOI：
10.1164/ajrccm.164.7.2003140
发表时间：
2001-10-01
影响因子：
24.7
作者：
King, TE;Tooze, JA;Cherniack, RM
通讯作者：
Cherniack, RM